✦ LIBER ✦

Diabetes and Cardiovascular Mortality in Men With Locally Advanced Prostate Cancer: Updated Analysis From RTOG 92-02

✍ Scribed by Mak, K.S.; Yan, Y.; Smith, M.R.; Hanks, G.E.; Brereton, H.D.; Bauman, G.; Rosenthal, S.A.; Zeitzer, K.L.; Sandler, H.M.; Efstathiou, J.A.

Book ID: 122497920
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 54 KB
Volume: 84
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2012.07.246

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular Mortality and Duration of

Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02

✍ Jason A. Efstathiou; Kyounghwa Bae; William U. Shipley; Gerald E. Hanks; Miljenk 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 200 KB

Editorial Comment on: Cardiovascular Mor

Editorial Comment on: Cardiovascular Mortality and Duration of Androgen Deprivation for Locally Advanced Prostate Cancer: Analysis of RTOG 92-02

✍ Peter Whelan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Obesity and mortality in men with locall

Obesity and mortality in men with locally advanced prostate cancer : Analysis of RTOG 85-31

✍ Jason A. Efstathiou; Kyounghwa Bae; William U. Shipley; Gerald E. Hanks; Miljenk 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

## Abstract ## BACKGROUND. Greater body mass index (BMI) is associated with shorter time to prostate‐specific antigen (PSA) failure following radical prostatectomy and radiation therapy (RT). Whether BMI is associated with prostate cancer‐specific mortality (PCSM) was investigated in a large rando

Surrogate endpoints for prostate cancer-

Surrogate endpoints for prostate cancer-specific mortality after radiotherapy and androgen suppression therapy in men with localised or locally advanced prostate cancer: an analysis of two randomised trials

✍ Anthony V D'Amico; Ming-Hui Chen; Mario de Castro; Marian Loffredo; David S Lamb 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 145 KB

Re: Surrogate Endpoints for Prostate Can

Re: Surrogate Endpoints for Prostate Cancer-Specific Mortality After Radiotherapy and Androgen Suppression Therapy in Men With Localised or Locally Advanced Prostate Cancer: An Analysis of Two Randomised Trials

✍ Walsh, Patrick C. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 113 KB

Balancing Competing Risks of Recurrence

Balancing Competing Risks of Recurrence and Death from High-risk Prostate Cancer Versus Cardiovascular Mortality in Men Treated With Hormonal Therapy: A Decision Analysis

✍ Lester-Coll, N.; Goldhaber, S.Z.; Sher, D.J.; D'Amico, A.V. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB